Lantern Pharma Inc (LTRN)

09:34 AM

Is Lantern Pharma Inc. stock a contrarian buyJuly 2025 Highlights & AI Forecasted Stock Moves - ulpravda.ru

09:34 AM

Jan 07, 2026

Why Lantern Pharma Inc. stock attracts global investorsEarnings Date Calendar & Top Analyst Picks Available for Free - ulpravda.ru

Jan 07, 2026

Jan 07, 2026

Lantern Pharma (NASDAQ:LTRN) Stock Price Up 6.2% – What’s Next? - Defense World

Jan 07, 2026

Jan 01, 2026

What analysts say about Lantern Pharma Inc stockMarket Capitalization Trends & Superior Capital Growth - earlytimes.in

Jan 01, 2026

Dec 31, 2025

Lantern Pharma Inc Stock Analysis and ForecastMACD Histogram Signals & Fast Profit Trading Strategies - earlytimes.in

Dec 31, 2025

Dec 22, 2025

Is Lantern Pharma Inc a good long term investmentResistance Breakout Alerts & Learn to Trade with Real-Time Feedback - earlytimes.in

Dec 22, 2025

Dec 21, 2025

Sentiment Recap: Is Lantern Pharma Inc. stock a safe buy before earningsWeekly Profit Summary & Free Expert Approved Momentum Trade Ideas - moha.gov.vn

Dec 21, 2025

Dec 20, 2025

What Wall Street predicts for Lantern Pharma Inc. stock priceJuly 2025 Update & Verified Entry Point Signals - Улправда

Dec 20, 2025

Dec 20, 2025

Lantern Pharma’s AI Bet Needs 2026 Trial Wins - Finimize

Dec 20, 2025

Dec 19, 2025

What momentum indicators show for Lantern Pharma Inc. stockEarnings Miss & AI Optimized Trade Strategies - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Why Lantern Pharma Inc. stock remains resilientNew Guidance & Target Return Focused Stock Picks - Улправда

Dec 18, 2025

Dec 16, 2025

Lantern Pharma (NASDAQ:LTRN) Shares Down 6.4% – Should You Sell? - Defense World

Dec 16, 2025

Dec 15, 2025

Lantern Pharma Earnings Notes - Trefis

Dec 15, 2025

Dec 14, 2025

Analyst Upgrade: Why Lantern Pharma Inc stock is rated strong buyTrade Entry Summary & Daily Chart Pattern Signals - moha.gov.vn

Dec 14, 2025

Dec 10, 2025

Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daily Commercial

Dec 10, 2025

Dec 05, 2025

Lantern Pharma announces LP-184 clinical trial met all primary endpoints - MSN

Dec 05, 2025

Dec 05, 2025

Lake Street Remains a Buy on Lantern Pharma (LTRN) - The Globe and Mail

Dec 05, 2025

Dec 04, 2025

Lantern Pharma (NASDAQ: LTRN) Details Encouraging LP-184 Phase 1a Results Showing Durable Disease Control in Advanced Solid Tumors - Digital Journal

Dec 04, 2025

Dec 04, 2025

Will Lantern Pharma Inc. stock benefit from automationTreasury Yields & AI Forecasted Stock Moves - Newser

Dec 04, 2025

Dec 04, 2025

Will Lantern Pharma Inc. stock rally after Fed decisionsPortfolio Return Report & Low Volatility Stock Suggestions - Newser

Dec 04, 2025

Dec 04, 2025

Lantern Pharma advances AI-Driven cancer drug after successful Phase 1a trial - Proactive financial news

Dec 04, 2025

Dec 03, 2025

Lantern’s cancer drug LP-184 shows promise in phase 1a trial - Investing.com Australia

Dec 03, 2025

Dec 03, 2025

Lantern Pharma (LTRN) Advances with Promising Clinical Insights from Phase 1a Study - GuruFocus

Dec 03, 2025

Dec 03, 2025

Lantern Pharma reports additional positive LP-184 Phase 1a results showing durable disease control in heavily pre-treated advanced cancer patients - marketscreener.com

Dec 03, 2025

Dec 03, 2025

Lantern’s cancer drug LP-184 shows promise in phase 1a trial By Investing.com - Investing.com South Africa

Dec 03, 2025

Dec 03, 2025

Lantern Pharma Reports Positive Phase 1a Data For LP-184 In Advanced Solid Tumors - Nasdaq

Dec 03, 2025

Dec 03, 2025

Lantern Pharma Inc. (LTRN) Rises 9.5% in Pre-market: Amid Routine Trading - Stocks Telegraph

Dec 03, 2025

Dec 03, 2025

Lantern Pharma Reports Additional Positive LP-184 Phase 1a Results Showing Durable Disease Control in Heavily Pre-Treated Advanced Cancer Patients as Company Advances Precision Oncology Program into Multiple Biomarker-Guided Phase 1b/2 Trials - Yahoo Finance

Dec 03, 2025

Nov 30, 2025

Can Jai Balaji Industries Limited Sustain EPS Growth Under Competitive PressureMorning Star Patterns & Zero-Cost Stock Research by Professionals - earlytimes.in

Nov 30, 2025

Nov 25, 2025

BIOS Capital Management LP Sells 131,757 Shares of Lantern Pharma Inc. $LTRN - Defense World

Nov 25, 2025

Nov 21, 2025

Is Lantern Pharma Inc. stock vulnerable to regulatory risksTrade Volume Report & Real-Time Chart Breakout Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Is Lantern Pharma Inc. stock oversold or undervaluedJuly 2025 News Drivers & Entry and Exit Point Strategies - newser.com

Nov 21, 2025

Nov 21, 2025

How Lantern Pharma Inc. stock reacts to global recession fearsMarket Activity Report & Reliable Volume Spike Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Here's Why Lantern Pharma (NASDAQ:LTRN) Must Use Its Cash Wisely - Sahm

Nov 21, 2025

Nov 19, 2025

Can Lantern Pharma Inc. stock deliver consistent earnings growth2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com

Nov 19, 2025

Nov 19, 2025

Is Lantern Pharma Inc. stock a buy before product launchesTrade Entry Summary & Daily Growth Stock Investment Tips - newser.com

Nov 19, 2025